The Clinical Effectiveness of Frequently Used Herbal Medicines for Cerebrovascular Disease: A Retrospective Study
![]() |
Seo, Hee-jeong
(Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University)
Shim, So-hyun (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University) Kwon, Jung-nam (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University) Hong, Jin-woo (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University) Lee, In (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University) |
1 | 韓東錫. 東醫壽世保元註釋. Seoul: 杏林出版社;1967, p. 300-45. |
2 | Han BS, Bae YC, Song SY, Park HS, Lee JH, Kim KY. Antioxidant effects and its mechanism of Cheongsi-myeonjatang in Sasang Constitutional Medicine. J of Sasang Constitutional Medicine 2004;16(1):130-47. |
3 | Jung DY, Ha Hk, Lee HY, Lee JA, Lee NH, Lee JK, et al, Stimulation of the Immune Response by Herbal Formulas for Taeeumin. J of Sasang Constitutional Medicine 2010;22(3):141-51. |
4 | Park SC. Effects CheongSimYeonJaTang(CSYJT) on control of immune-function in highly purified mouse B cells and Mast cell. J Sasang Constitut Med 2003;15(2):166-79. |
5 | Barlas RS, Honney K, Loke YK, McCall SJ, Bettencourt-Silva JH, Clark AB, et al. Impact of hemoglobin levels and anemia on mortality in acute stroke: analysis of UK regional registry data, systematic review, and meta-analysis. J Am Heart Assoc 2016;5(8):e003019. DOI |
6 | Seo CS, Jeong SJ, Kim JH, Yoo SR, Shin Hyeun-Kyoo. Simultaneous Analysis and Anti-obesity Effect of Taeeumin Cheongsimyeonja-tang. J Sasang Constitut Med 2013;25(1):51-61. DOI |
7 | Yoon YS, Keum SO, Lee SW, Kim IH, Lee HI, Song YS. Effects of Cheongshimyeonja-tang on Body Weight and Serum Lipid Levels in High Fat Diet Induced Obese Mice. Herbal Formula Science 2014;22(1):123-39. DOI |
8 | Ju LS, Ahn TW. Study of Cheongsimyeonja-tang that get weight, hematology, biochemistry change by Wistar rat's aging. J Daejeon Orient Med 2004;13(2):337-45. |
9 | Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003;289(5):579-88. DOI |
10 | Lee JA, Ha Hk, Lee HY, Jung DY, Lee JK, Huang DS, et al. Anti-inflammatory Activities of Herbal Formulas for Sasang Constitutional Medicine. J of Sasang Constitutional Medicine 2010;22(4):56-64. |
11 | Seo CS, Jeong SJ, Kim JH, Yoo SR, Shin HK. Simultaneous Analysis and Anti-obesity Effect of Taeeumin Cheongsimyeonja-tang. J Sasang Constitut Med 2013;25(1):51-61. DOI |
12 | Yoon YS, Keum SO, Lee SW, Kim IH, Lee HI, Song YS. Effects of Cheongshimyeonja-tang on Body Weight and Serum Lipid Levels in High Fat Diet Induced Obese Mice. Herbal Formula Science 2014;22(1):123-39. DOI |
13 | Han BS, Ryu DG, Lee SW, Kim KO. Effects of the Chungsimyonjatang water Extract on the Rat Myocardial Cells in Cultures. J Sasang Constitut Med 2001;13(1):70-8. |
14 | Yoon HD, Shin OC, Shin YJ, Kim SM. Effect of Chungsimyeonjatang on Myocardiac Cell Injury in Mouse Myoblast C2C12 Cells. J Orient Int Korean Med 2007;28(2):333-45. |
15 | Park JH, Kim KY. Effect of Taeumin Chungsimyoinjatang Extract on Blood Pressure and Regional Cerebral Blood Flow in Rats. J Sasang Constitut Med 2000;12(1):216-27. |
16 | Kim YJ, Kim TW, Seo CS, Park SR, Ha Hk, Shin HK, et al. Quatification of Flavonoid Contents in Chungsimyeonja-tang, a Multi-Herbal Decoction, and Its Protective Effect against Cisplatin-induced Nephrotoxicity. Natural Product Sciences 2014;20(4):251-7. |
17 | Kim MW. The Cure Effect of Cheongsimyeonjatang on Atopic Dermatitis by Regulation of Th2 Cell Differentiation and Anti-Inflammatory Mechanism. Dongguk university Doctor's degree 2006. |
18 | Kim SW. Effect of Yuldahansotang and Chung -simyeonjatang on the Hepatic Injury. Woosuk University Master's degree 2001. |
19 | Ha JH. Comparative Efficacy Study of Hyeong banggiwhang-tang, Cheongsimyeonja-tang and Hyangsayangyi-tang on the 5/6 Nephrectomy induced Chronic Renal Failure Rats. Daegu Haany University Doctor's degree 2013. |
20 | 許浚. 東醫寶鑑. Seoul: 南山堂; 1983, p. 366. |
21 | 李梴. 醫學入門. Seoul: 翰成社; 1980, p. 525. |
22 | 尹吉榮. 東醫臨床方劑學. Seoul: 明寶出版社; 1985, p. 99. |
23 | 成都中醫學院方劑敎硏組. 中醫治法學方劑. 北京: 人民衛生出版社; 1985, p. 208-12. |
24 | Shin WT, Heo JE, Kim TH, Hong SH, Kwon OS, Kim KT, Hong SH. Clinical Effect of Dodam-tang on Hyperlipidemia Patients. J Int Korean Med 2007;fal:113-8. |
25 | Kim YD, Moon BS, Park YS, Kim SG. Effects of Dodamtang(導痰湯) on the Hyperlipidemia and Intravascular Coagulation Induced Rabbits. The Journal of Wonkang Oriental Medicine 1994;4(1):85-128. |
26 | Lee WC, Kim JH. Oriental treatment of neurological diseases Seoul: Jeongdam book publishing; 2005, p. 433. |
27 | Choi JH, Jeong HW. Effects of Dodamtang and Its Gamypang on the Regional Cerebral Blood Flow and Blood Pressure in Rats. J Physiol & Pathol Korean 2000;14(1):99-106. |
28 | Nationwide professors of Herbal formula study co-edit. The herbal formula study Seoul: Yunglim publisher; 2008, p. 410-3. |
29 | Wang CI. EuiLimGaeChak iksan: Wonhakkyo; 1998, p. 89-96, 168. |
30 | 陈桂铭. 补肾益脑汤治疗老年性痴呆的体会. Doctor's degree 1992. |
31 | 王文超. 补肾益脑汤治疗血管性痴呆床硏究.. Doctor's degree 2012. |
32 | 李正树, 彭华, 杨传东, 张晓勤. 补肾益脑汤治疗老年性痴呆23例. 吉林中医药 1995;5:6-7. |
33 | Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27(3):373-80. |
34 | Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association. Stroke 2006;37(6):1583-633. DOI |
35 | Statistics-Korea: Population projections for Korea : 2017-2067. In: http://kostat.go.kr/portal/korea/kor_nw/1/1/index.board?bmode=read&aSeq=373873. Statistics Korea; 2019 |
36 | Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet 2014;383(9913):245-55. DOI |
37 | Wolf PA, D'Agostino RB, O'Neal MA, Sytkowski P, Kase CS, Belanger AJ, et al. Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 1992;23(11):1551-5. DOI |
38 | American Heart Association, Heart Disease and Stroke Statistics-2004 Update. Dallas, Tex American Heart Association. 2003. |
39 | Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360(9349):1903-13. DOI |
40 | Clinical research center for stroke. Korean Clinical Practice Guidelines for Stroke (revised edition). 2013 Feb; [cited 2016 Dec 27]. Available at: URL: http://www.stroke-crc.or.kr/%EB %87%8C%EC%A1%B8%EC%A4%91%EC%A7%84%EB%A3%8C%EC%A7%80%EC%B9%A8%2020130322.pdf |
41 | Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis. Stroke 2004;35(12):2902-9. DOI |
42 | Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22(8):983-8. DOI |
43 | O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376(9735):112-23. DOI |
44 | Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD. A study of twins and stroke. Stroke 1992;23(2):221-3. DOI |
45 | Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989;298(6676):789-94. DOI |
46 | Robbins AS, Manson JE, Lee IM, Satterfield S, Hennekens CH. Cigarette smoking and stroke in a cohort of U.S. Male physicians. Ann Intern Med 1994;120(6):458-62. DOI |
47 | Statistics-Korea: Cause of death statistics : 2017. In : http://www.kostat.go.kr/portal/korea/kor_nw/1/6/2/index.board?bmode=read&bSeq=&aSeq=370710&pageNo=1&rowNum=10&navCount=10&currPg=&searchInfo=&sTarget=title&sTxt=. Statistics Korea; 2018. |
48 | Ministry of Health and Welfare. Survey on Korean medicine use and consumption 2014. 2011 Dec 7; [cited 2016 Dec 27]. Available at: URL:http://www.prism.go.kr/homepage/theme/retrieveThemeDetail.do;jsessionid=8C0E78708F3DAB1DD75E9C6186430BE8.node02?cond_research_name=&cond_organ_id=&cond_research_year_start=&cond_research_year_end=&cond_brm_super_id=NB000120061201100060495&research_id=1351000-201100127&pageIndex=6&leftMenuLevel=110. |
49 | Kim MK, Han CH. E-mail survey on the current status of clinical practice and activation measures for Korean medicine in stroke care. J Korean Med 2017;38(3):143-59. DOI |
50 | WHO. Global Health Estimates 2016 : CAUSE-SPECIFIC MORTALITY, 2000-2016. 2017. |
51 | Lee SW, Kim HC, Lee HS, Suh I. Thirty-Year Trends in Mortality from Cerebrovascular Diseases in Korea. Korean Circ J 2016;46(4):507-14. DOI |
52 | Korea Centers for Disease Control and Prevention. A study on Measuring the Economic Burden of Cardio-Cerebrovascular Diseases in Korea. Korea University 2010. |
![]() |